相关实验视频

Updated: Jul 22, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

转移性黑色素瘤采用T细胞治疗的进展

Aparimita Das¹, Aruni Ghose², Kevin Naicker³

¹Department of Medical Oncology, Medway NHS Foundation Trust, Windmill Road, ME7 5NY, Gillingham, Kent, United Kingdom; Faculty of Allied Health Sciences, Chettinad Academy of Research and Education, Chennai, India.

Current research in translational medicine

|July 21, 2023

概括

采用T细胞疗法 (ACT) 对转移性黑色素瘤 (MM) 显示出有前途. 虽然ACT有效,但它面临着诸如自身免疫性毒性等挑战,需要对组合疗法的持续研究以改善结果.

科学领域:

免疫治疗是一种免疫疗法.
在瘤学瘤学.
细胞疗法细胞疗法

背景情况:

收养性T细胞疗法 (ACT) 是一种快速发展的免疫疗法 (IO) 模式.
它正在彻底改变固体瘤瘤学,特别是转移性黑色素瘤 (MM).
ACT利用瘤抗原 (TA) 通过瘤透淋巴细胞 (TIL) 或转基因T细胞 (TCR,CAR) 或NK细胞向癌细胞.

研究的目的:

审查ACT在转移性黑色素瘤中的作用和发展.
探索各种ACT模式,包括它们的安全性,有效性和风险.
讨论ACT对MM的当前试验和现实世界的设置.

主要方法:

2006年至今的MM中ACT临床试验和研究的文献综述.
分析不同的ACT模式:TILs,TCR-ACT,CAR-T和NK细胞治疗方法.
检查安全概况,疗效数据和相关的毒性.

主要成果:

临床试验表明,在MM中ACT的结果很有希望.
显著的挑战包括自身免疫性毒性和淋巴细胞减少的要求.
目前正在进行的研究重点是免疫调节和组合疗法,以提高疗效和减少不良影响.

结论:

ACT代表了MM治疗的重大进步.
解决毒性和优化治疗策略对于更广泛的临床应用至关重要.
进一步的研究和临床试验至关重要,以完善ACT以改善患者的治疗结果.

关键词:

收养T细胞疗法采用T细胞疗法黑色素瘤是一种黑色素瘤.自然杀手细胞是自然杀手细胞.T细胞受体的T细胞受体.治疗疗法治疗疗法瘤透到淋巴细胞中.嵌合式抗原受体嵌合式抗原受体

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...